Building on the foundation of GE Healthcare’s CT platform, the LightSpeed VCT XT is reportedly capable of capturing images of the heart and coronary arteries in as few as five heartbeats. With SnapShot Pulse, the LightSpeed VCT XT reduces a patient’s X-ray exposure time by up to 70 percent for diagnostic cardiac scans, using a process called prospective triggered gating.

The Toshiba Aquilion CT line’s product platform design reportedly allows for all customers to benefit from Toshiba’s Quantum Advantage, delivering the industry’s thinnest slice thickness at 0.5-millimeter isotropic slices, whether using an Aquilion 4-slice, 8-slice, 16-slice, 32-slice or 64-slice.

Siemens Medical Solutions received FDA 510(k) clearance for a 1.5 Tesla (T) magnetic resonance imaging (MRI) system that is reportedly more affordable, allowing providers to upgrade from low-field MRI systems or to add an MRI system for the first time.


Safe medication administration at the hospital bedside is not simply a matter of a nurse handing out the right meds at the right time and to the right patient, of course. Today, the practice is a cooperative effort between the nursing staff and the pharmacy working to maximize the benefits of information technology solutions, such as bar coding and wireless.


The clinical definition of intraoperative awareness — consciousness during general anesthesia — is a seemingly simple explanation for a complex, and controversial, phenomenon. Opinions surrounding how often intraoperative awareness, also described as anesthesia awareness, occurs, its implications for victims, as well as the best methods for prevention are varied.

Despite advances in our understanding of the pathophysiology of pain and the pharmacology of analgesic drugs, as well as increasing emphasis on adequate pain management [1], pain control remains inadequate in hospitalized patients.

October 16, 2007 - MIV Therapeutics Inc., a developer of coatings and drug delivery systems for cardiovascular stents, will present results from the first-in-man safety study with the its drug-eluting stent at the Transcatheter Cardiovascular Therapeutics (TCT) 2007 conference, to be held October 20-25 at the Washington Convention Center in Washington, D.C.

October 16, 2007 - Abiomed Inc. will be presenting clinical data on Impella 2.5 percutaneous Ventricular Assist Device (VAD), including results from a multi-center feasibility study of adult patients that had high-risk Percutaneous Coronary Interventions (PCI), at the Cardiovascular Research Foundation’s (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting, scheduled from Saturday, October 20, to Thursday, October 25, in Washington, D.C.

October 16, 2007 – Celera developed a five-gene genetic risk score based on five variant genes that predict risk for coronary heart disease (CHD), according to a study published in the October 2007 edition of Genetics in Medicine, marking the potential development of personalized disease management in the cardiovascular arena.

October 16, 2007 — In response to Medtronic’s decision to voluntarily suspend its Sprint Fidelis defibrillation leads, the Heart Rhythm Society (HRS) made a statement to underscore the importance of the society’s task force recommendations for the surveillance, analysis and performance reporting of pacemakers and implantable cardioverter defibrillators (ICDs).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now